Hilin-Ace Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg and Diacerein 50 mg, indicated for the management of osteoarthritis and other musculoskeletal disorders characterized by pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and swelling. Diacerein, an anthraquinone derivative, provides symptomatic relief by modulating interleukin-1 activity and promoting cartilage repair, thereby addressing both symptoms and disease progression in osteoarthritis. The combination of these two agents offers enhanced efficacy in reducing joint pain, stiffness, and improving mobility while minimizing the need for higher doses of individual drugs. Hilin-Ace is typically administered orally, with dosage and duration tailored according to clinical response and patient tolerance. Caution is advised in patients with gastrointestinal disorders, hepatic or renal impairment, and those with known hypersensitivity to NSAIDs or diacerein. Common adverse effects may include gastrointestinal discomfort, diarrhea, and skin reactions. Regular monitoring and adherence to prescribed dosage are essential to optimize therapeutic outcomes and minimize potential risks. Hilin-Ace Tablet should be used under medical supervision.